Literature DB >> 10547466

Treatment of recurrent pleomorphic adenomas of the parotid gland.

J F Carew1, R H Spiro, B Singh, J P Shah.   

Abstract

Recurrent pleomorphic adenomas (RPAs) of the parotid gland are an uncommon but challenging problem. The records of 31 patients with RPAs were reviewed to assess the clinical presentation and treatment results. More than half of these patients underwent total parotidectomy. Local control was achieved in 94% of patients at 7 years (median follow-up 7.3 years). Patients who had surgery for recurrence after a formal parotidectomy were more likely to have another recurrence (63% local control at 7 years) than patients whose initial procedure was a limited excision (100% local control at 7 years; P < 0.01). Better local control was seen in 11 patients who received postoperative irradiation (100% at 10 years) than in 20 patients who did not (71% at 10 years; P < 0.28). Adequate surgical resection yields an acceptable local control rate in patients with RPAs. Postoperative radiation therapy may improve control in patients at high risk for another recurrence.

Entities:  

Mesh:

Year:  1999        PMID: 10547466     DOI: 10.1016/S0194-5998(99)70053-7

Source DB:  PubMed          Journal:  Otolaryngol Head Neck Surg        ISSN: 0194-5998            Impact factor:   3.497


  9 in total

1.  The role of adjuvant radiotherapy in management of recurrent pleomorphic adenoma of the parotid gland: a systematic review.

Authors:  Laura Mc Loughlin; Sarah Louise Gillanders; Susan Smith; Orla Young
Journal:  Eur Arch Otorhinolaryngol       Date:  2018-11-13       Impact factor: 2.503

2.  Surgical management of parapharyngeal space tumours: results of 10-year follow-up.

Authors:  F Bozza; M G Vigili; P Ruscito; A Marzetti; F Marzetti
Journal:  Acta Otorhinolaryngol Ital       Date:  2009-02       Impact factor: 2.124

3.  Extracapsular Dissection vs Superficial Parotidectomy of Benign Parotid Lesions: Surgical Outcomes and Cost-effectiveness Analysis.

Authors:  Masanari G Kato; Evren Erkul; Shaun A Nguyen; Terry A Day; Joshua D Hornig; Eric J Lentsch; M Boyd Gillespie
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2017-11-01       Impact factor: 6.223

4.  Imaging characteristics of recurrent pleomorphic adenoma of the parotid gland.

Authors:  G Moonis; P Patel; Y Koshkareva; J Newman; L A Loevner
Journal:  AJNR Am J Neuroradiol       Date:  2007-09       Impact factor: 3.825

5.  Clinical manifestations of recurrent parotid pleomorphic adenoma.

Authors:  Myung-Whan Suh; J Hun Hah; Seong Keun Kwon; Young-Ho Jung; Tack-Kyun Kwon; Kwang Hyun Kim; Myung-Whun Sung
Journal:  Clin Exp Otorhinolaryngol       Date:  2009-12-31       Impact factor: 3.372

6.  Recurrent Parotid Pleomorphic Adenomas: Our Clinical Experience.

Authors:  Özgür Kümüş; Ahmet Ömer İkiz; Sülen Sarıoğlu; Taner Kemal Erdağ
Journal:  Turk Arch Otorhinolaryngol       Date:  2016-09-01

7.  Radiation Therapy After Surgical Resection Improves Outcomes for Patients With Recurrent Pleomorphic Adenoma.

Authors:  Sarah E Nicholas; Wei Fu; Angela L Liang; Regina DeLuna; Luka Vujaskovic; Justin Bishop; Brandi R Page; Harry Quon; Christine Gourin; Carole Fakhry; David Eisele; Ana P Kiess
Journal:  Adv Radiat Oncol       Date:  2021-03-02

8.  Management and prognostic factors of recurrent pleomorphic adenoma of the parotid gland: personal experience and review of the literature.

Authors:  Luca Oscar Redaelli de Zinis; Michela Piccioni; Antonino Roberto Antonelli; Piero Nicolai
Journal:  Eur Arch Otorhinolaryngol       Date:  2007-10-25       Impact factor: 2.503

9.  Parotid neoplasms: analysis of 600 patients attended at a single institution.

Authors:  Ademar Takahama Junior; Oslei Paes de Almeida; Luiz Paulo Kowalski
Journal:  Braz J Otorhinolaryngol       Date:  2009 Jul-Aug
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.